2008
DOI: 10.1016/j.cca.2007.10.023
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of nutritional and genetic determinants of total homocysteine, methylmalonic acid and S-adenosylmethionine/S-adenosylhomocysteine values in Brazilian childbearing-age women

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
9
1
2

Year Published

2008
2008
2017
2017

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 18 publications
(15 citation statements)
references
References 42 publications
3
9
1
2
Order By: Relevance
“…Individuals with the TT genotype have increased dietary folate requirements because they have lower RBC folate levels compared with those without this genetic variant, and the increase in tHcy is found mostly in patients with folate deficiency. However, in our study, mean RBC folate level and mean plasma concentration of Hcy did not vary significantly by genotype, and no correlation between folate intake and circulating levels stratified by genotype were found, also considering pregnancy and smoking status, confirming previous results reported in the general population [30], in women of childbearing age [31] and in folic acid-supplemented pregnant women [8]. Nevertheless, our results should be interpreted with caution due to the small number of women studied.…”
Section: Discussionsupporting
confidence: 81%
“…Individuals with the TT genotype have increased dietary folate requirements because they have lower RBC folate levels compared with those without this genetic variant, and the increase in tHcy is found mostly in patients with folate deficiency. However, in our study, mean RBC folate level and mean plasma concentration of Hcy did not vary significantly by genotype, and no correlation between folate intake and circulating levels stratified by genotype were found, also considering pregnancy and smoking status, confirming previous results reported in the general population [30], in women of childbearing age [31] and in folic acid-supplemented pregnant women [8]. Nevertheless, our results should be interpreted with caution due to the small number of women studied.…”
Section: Discussionsupporting
confidence: 81%
“…In addition to the MTHFR gene, other genetic polymorphisms involved in the folate pathway seem to modulate the maternal risk for bearing a child with DS (Bosco et al, 2003;J.M. Biselli et al, 2008a;Meguid et al, 2008;Pozzi et al, 2009;Sadiq et al, 2011;Scala et al, 2006;Wang et al, 2008) as well as the concentrations of metabolites involved in the folate pathway (Ananth et al 2007;Barbosa et al, 2008;Cheng et al, 2010;Devos et al, 2008). The MTR 2756 A→G polymorphism has been associated with increased maternal risk for DS in the presence of AG or GG genotypes, as well as when combined with polymorphisms MTRR 66 A→G (MTR 2756AG/MTRR 66AG) (Bosco et al, 2003) and MTHFR 677 C→T (MTHFR 677TT/MTR 2756AA).…”
Section: Folate Metabolism Genomic Stability and Maternal Risk For mentioning
confidence: 99%
“…The prevalence of folate and cobalamin deficiency during pregnancy is relatively high in some countries of Sub-Saharan Africa, northern Europe and in Brazil [5][6][7][8]. Disorders in the maternalfetal homocysteine (Hcy) metabolism due to folate and/or cobalamin deficiencies are related to a wide array of pathological conditions, such as recurrent miscarriages, placental abruption, preeclampsia, neural tube closure defects and intrauterine growth retardation [9][10][11][12][13].…”
Section: Introductionmentioning
confidence: 99%